Xencor (XNCR) Capital Leases (2013)

Xencor's (XNCR) quarterly Capital Leases came in at $1000.0 in Q4 2013.

Xencor (XNCR) Capital Leases (2013) Analysis & Trends

Xencor (XNCR) has 1 years of Capital Leases data on file, last reported at $1000.0 in Q4 2013.

On a quarterly basis, Capital Leases changed N/A year-over-year to $1000.0 in Q4 2013; TTM through Dec 2013 was $1000.0, a N/A change from a year earlier, with the FY2013 full-year figure at $1000.0, changed N/A from the prior year.
Capital Leases for Q4 2013 stood at $1000.0.
Over the last five years, Capital Leases for XNCR reached as high as $1000.0 in Q4 2013 and fell as low as $1000.0 in Q4 2013.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Xencor	1.47 Bn	1.09 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2013	1,000.00